Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.6M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
+531K
-
Total reported value, excl. options
-
$622M
-
Value change
-
+$3.01M
-
Put/Call ratio
-
0.84
-
Number of buys
-
39
-
Number of sells
-
-52
-
Price
-
$16.90
Significant Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q1 2022
115 filings reported holding ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share as of Q1 2022.
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
of 54.6M outstanding shares and own 67.36% of the company stock.
Largest 10 shareholders include venBio Partners LLC (9.7M shares), Vivo Capital, LLC (4.22M shares), FMR LLC (3.56M shares), Logos Global Management LP (3.01M shares), WELLINGTON MANAGEMENT GROUP LLP (2.81M shares), STATE STREET CORP (2.13M shares), VANGUARD GROUP INC (1.68M shares), BlackRock Inc. (1.36M shares), Redmile Group, LLC (772K shares), and Cormorant Asset Management, LP (712K shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.